PerClot potentially negatively impacts which phase of wound healing?

Prepare for the Arista AH and Surgical Hemostats Test with engaging flashcards and detailed questions, complete with explanations and hints to help you succeed in your exam!

Multiple Choice

PerClot potentially negatively impacts which phase of wound healing?

Explanation:
During wound healing, the inflammatory phase is the initial response where immune cells clear debris and fight infection. PerClot, as a topical hemostatic agent, can irritate tissue or leave behind residues that act as a foreign body. This tends to trigger a stronger and sometimes prolonged inflammatory response. Because inflammation is meant to be temporary, an exaggerated or extended inflammatory reaction delays the switch to the proliferative phase (new tissue formation) and the subsequent maturation phase (remodeling). So PerClot can negatively impact the inflammatory phase by amplifying and extending the inflammatory response, hindering overall healing.

During wound healing, the inflammatory phase is the initial response where immune cells clear debris and fight infection. PerClot, as a topical hemostatic agent, can irritate tissue or leave behind residues that act as a foreign body. This tends to trigger a stronger and sometimes prolonged inflammatory response. Because inflammation is meant to be temporary, an exaggerated or extended inflammatory reaction delays the switch to the proliferative phase (new tissue formation) and the subsequent maturation phase (remodeling). So PerClot can negatively impact the inflammatory phase by amplifying and extending the inflammatory response, hindering overall healing.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy